Answers are grounded in this paper and cite their sources.
This case report examines listeriosis in an immunocompromised woman with COVID-19, highlighting treatment outcomes.
We present the case of a young, immunocompromised woman with invasive listeriosis who initially presented with respiratory symptoms after being diagnosed with COVID-19. She had a 6-day history of nasal discharge, malaise, and headache, with positive COVID-19 PCR results. A blood culture revealed Listeria monocytogenes with an elevated initial cerebrospinal fluid pressure, pleocytosis, and reduced glucose levels. On presentation, she was alert and successfully treated with intravenous ampicillin for three weeks, with no neurological sequelae.
No takes yet. Share an insight, caveat, or question.
Higuchi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: